The AJCC staging is based on three main characteristics defining the natural history of melanoma; namely the extent of the primary tumor (T), the absence or presence of regional lymph node metastasis ...
This guide provides an informative and educational overview of stage 3 papillary thyroid cancer (PTC) to help drive a ...
Castle Biosciences, Inc. will present innovative research on cutaneous melanoma (CM) and uveal melanoma (UM) at the 2025 ASCO Annual Meeting in Chicago, showcasing findings from a collaboration with ...
Patients identified as low risk by DecisionDx-Melanoma had a 2.8% sentinel lymph node (SLN) positivity rate, well below the National Comprehensive Cancer Network® (NCCN) guidelines’ 5% threshold to ...